Scientist Cancer Target Drug Discovery

Company: Seattle Genetics
Location: Bothell
Posted on: January 27, 2023

Job Description:

Description



Position at Seagen





Seagen is a global, multi-product biotechnology company dedicated to developing and commercializing transformative cancer medicines. As the industry leader in antibody-drug conjugate (ADC) technology, we pioneered a new generation in the science of harnessing antibodies to deliver cell-killing agents directly to cancer cells. Seagen's dedication to improving the lives of cancer patients goes beyond science, and we believe that every employee has a role in contributing to this mission. By working together with a shared dedication and diverse perspectives, we are able to reach our full potential and make a real difference in the world. Seagen is a fast-growing company and has an abundance of opportunities available for you to grow your career. Put your passion to work at Seagen and join us! Summary: Seagen is seeking a highly skilled and collaborative scientist to perform research activities developing novel therapeutic agents in the Cancer Target Discovery (CTD) team. This individual will be responsible for research activities on cross-functional project teams interrogating cancer mechanisms of action and signaling pathways. They will play a critical role in supporting the Research department's cancer target discovery efforts to develop novel antibody-based therapeutics. They should have a sustained record of being a strong scientist, team player, strategic thinker, and an effective communicator. Principal Responsibilities:

• Expertise in cancer cell biology and signaling pathways focused on key biological areas of oncology
• Develops and executes research plans aimed at expanding our understanding of therapeutic MOAs
• Generate and organize technical data to deliver effective presentations in multiple forums
• Promote collaboration between project teams within Research
• May provide research support/oversight for external collaborations and/or MTAs and represent research on advisory boards Required Qualifications:
  • PhD with 0-2 years relevant experience; may include post-doctoral experience; or equivalent, such as M.S. with 6+ years relevant experience; Bachelor's degree with 8+ years relevant experience
  • A degree in the following or related preferred: Cell Biology, Cancer Biology, Biochemistry, Bioengineering Preferred Qualifications:
    • Strong background in experimental cancer biology, biochemical and/or immunological techniques (e.g., ELISA, western blot, CRISPR, lentiviral delivery, immunofluorescence, flow cytometry)
    • Broad knowledge of cancer cell signaling and genetics
    • Experience with mining cancer genomic databases (e.g. TCGA, DepMAP, GDSC)
    • Knowledge and expertise in oncology drug development, therapeutic antibodies, and/or ADCs
    • Strong written and verbal communication skills with the ability to communicate effectively to a wide range of audiences
    • Demonstrated record of publications in high-quality scientific journals and/or presentations at scientific conferences As the leading employer in our industry in the Pacific Northwest, Seagen is proud to offer a competitive total compensation package as well as a comprehensive benefits program designed to support the whole lives of our employees and their families. Benefits include medical, vision and dental coverage, group and supplemental life insurance, 401(k) with company match, tuition reimbursement, relocation assistance and much more. To learn more about Seagen, please visitwww.seagen.com. The hiring pay range for this position is $106,000 to $138,000 per year based on skills, education and experience relevant to the role. Other components of total compensation include a competitive equity grant at the time of hire (with additional annual grants, and grants upon promotion when applicable), and an annual bonus. Seagen is an equal opportunity employer. All qualified applications will receive consideration for employment without regard to race, age, gender identity, sexual orientation, color, religion, sex, marital status, national origin, protected veteran status, disability status, or any other status protected by federal, state, or local law. To prevent the spread of COVID-19, and as an integral part of its public health and safety measures, Seagen requires that all newly-hired employees be fully vaccinated against COVID-19 before commencing employment, subject to reasonable accommodation and other requirements of applicable federal, state, and local law.
      
      
      #LI-KO1
      
      
      
      

Keywords: Seattle Genetics, Seattle , Scientist Cancer Target Drug Discovery, Other , Bothell, Washington